A retrospective non-interventional study to evaluate the use of Seroquel extended release (XR) and Immediate Release (IR) in the clinical practice of inpatients with schizophrenia - SPIN

Study identifier:NIS-NSE-SER-2010/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A retrospective, non-interventional study to evaluate the use of Seroquel XR and Seroquel IR in the clinical practice of inpatients with schizophrenia

Medical condition

schizophrenia

Phase

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

300

Study type

Observational

Age

18 Years - 65 Years

Date

Study Start Date: 01 Oct 2010

Primary Completion Date: 01 Dec 2010

Study Completion Date: 01 Dec 2010

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

Location

Research Site

Falköping, Sweden

Location

Research Site

Gothenburg, Sweden

Location

Research Site

Helsingborg, Sweden

Location

Research Site

Karlskrona, Sweden

Location

Research Site

Karlstad, Sweden

Location

Research Site

Lund, Sweden

Location

Research Site

Malmö, Sweden

Location

Research Site

Mölndal, Sweden

Arms	Assigned Interventions
1 Patients with a diagnosis of schizophrenia who have been hospitalized and received at least one dose of Seroquel XR or Seroquel IR during the study period (1st of July 2009 – 30th of September 2010).	-

Documents available

CSR-NIS-NSE-SER-2010-1.pdf
Download
CSR-NIS-NSE-SER-2010-1.pdf
Download
Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Sweden Clinical Study Information

+46 (0)8 553 26 000

Investigators

Principal Investigator

Dr Eva Dencker Vansvik

AstraZeneca

A retrospective non-interventional study to evaluate the use of Seroquel extended release (XR) and Immediate Release (IR) in the clinical practice of inpatients with schizophrenia - SPIN

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Exclusion Criteria

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Documents available

CSR-NIS-NSE-SER-2010-1.pdf

CSR-NIS-NSE-SER-2010-1.pdf

Trial Results Summaries

Contacts

Contact

Investigators

Principal Investigator